PMH40 COST-EFFECTIVENESS OF RITALINTM VERSUS ADDERALLTM FOR FIRST-LINE TREATMENT OF ATTENTION DEFICIT/HYPERACTIVITY DISORDER (ADHD) IN CHILDREN
May 1, 2004, 00:00
10.1016/S1098-3015(10)62235-8
https://www.valueinhealthjournal.com/article/S1098-3015(10)62235-8/fulltext
Title :
PMH40 COST-EFFECTIVENESS OF RITALINTM VERSUS ADDERALLTM FOR FIRST-LINE TREATMENT OF ATTENTION DEFICIT/HYPERACTIVITY DISORDER (ADHD) IN CHILDREN
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)62235-8&doi=10.1016/S1098-3015(10)62235-8
First page :
Section Title :
Open access? :
No
Section Order :
173